Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of topical EG-Decorin for wound healing at split-thickness skin graft donor sites
KCT0003467Phase 2Completed
- Sponsor
- EyeGene, Inc.
- Start
- Feb 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 2 trial of decorin in wound, sponsored by EyeGene, Inc.. Started Feb 2019; status: completed.
02
Drugs
decorin
03
Conditions
wound
Beyond the preview
Go deeper on KCT0003467.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0003467.